Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers

Sylvia De Brakeleer, Marika Bogdani, Jacques De Grève, Julie Decock, Erica Sermijn, Maryse Bonduelle, Guido Goelen, Erik Teugels

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Enhanced genomic instability has been recently reported in normal cells derived from BRCA1/2 mutation carriers when placed in vitro in non-physiological stress conditions. We present here original data which help to explain the observed genomic instability. Leucocytes from BRCA1/2 mutation carriers, sporadic breast cancer patients and controls were prepared for BRCA1 immunocytochemistry. We show that BRCA1 containing nuclear dot like structures are detectable in about 80% of the leucocytes from controls and sporadic breast cancer patients, but are absent in the majority of normal cells from BRCA1 as well as BRCA2 mutation carriers (also in their normal breast cells). Our results thus indicate that the genomic instability observed in normal cells from BRCA1 and BRCA2 mutation carriers is associated with a down-regulation of nuclear BRCA1 protein accumulation in the dot like structures. These results suggest in addition that immunocytochemical or alternative molecular screening strategies might help to identify women with a high risk for breast (ovarian) cancer even when the underlying genetic defect remains undetectable.

Original languageEnglish
Pages (from-to)104-112
Number of pages9
JournalMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Volume619
Issue number1-2
DOIs
Publication statusPublished - 1 Jun 2007
Externally publishedYes

Fingerprint

BRCA1 Protein
Nuclear Proteins
Genomic Instability
Staining and Labeling
Mutation
Breast Neoplasms
Leukocytes
Ovarian Neoplasms
Breast
Down-Regulation
Immunohistochemistry

Keywords

  • BRCA1
  • BRCA2
  • Breast cancer
  • Immunocytochemistry

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Molecular Biology

Cite this

Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers. / De Brakeleer, Sylvia; Bogdani, Marika; De Grève, Jacques; Decock, Julie; Sermijn, Erica; Bonduelle, Maryse; Goelen, Guido; Teugels, Erik.

In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 619, No. 1-2, 01.06.2007, p. 104-112.

Research output: Contribution to journalArticle

De Brakeleer, Sylvia ; Bogdani, Marika ; De Grève, Jacques ; Decock, Julie ; Sermijn, Erica ; Bonduelle, Maryse ; Goelen, Guido ; Teugels, Erik. / Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers. In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 2007 ; Vol. 619, No. 1-2. pp. 104-112.
@article{9ceea374eb0644cbb37bfed292499895,
title = "Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers",
abstract = "Enhanced genomic instability has been recently reported in normal cells derived from BRCA1/2 mutation carriers when placed in vitro in non-physiological stress conditions. We present here original data which help to explain the observed genomic instability. Leucocytes from BRCA1/2 mutation carriers, sporadic breast cancer patients and controls were prepared for BRCA1 immunocytochemistry. We show that BRCA1 containing nuclear dot like structures are detectable in about 80{\%} of the leucocytes from controls and sporadic breast cancer patients, but are absent in the majority of normal cells from BRCA1 as well as BRCA2 mutation carriers (also in their normal breast cells). Our results thus indicate that the genomic instability observed in normal cells from BRCA1 and BRCA2 mutation carriers is associated with a down-regulation of nuclear BRCA1 protein accumulation in the dot like structures. These results suggest in addition that immunocytochemical or alternative molecular screening strategies might help to identify women with a high risk for breast (ovarian) cancer even when the underlying genetic defect remains undetectable.",
keywords = "BRCA1, BRCA2, Breast cancer, Immunocytochemistry",
author = "{De Brakeleer}, Sylvia and Marika Bogdani and {De Gr{\`e}ve}, Jacques and Julie Decock and Erica Sermijn and Maryse Bonduelle and Guido Goelen and Erik Teugels",
year = "2007",
month = "6",
day = "1",
doi = "10.1016/j.mrfmmm.2007.02.031",
language = "English",
volume = "619",
pages = "104--112",
journal = "Mutation Research",
issn = "0027-5107",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers

AU - De Brakeleer, Sylvia

AU - Bogdani, Marika

AU - De Grève, Jacques

AU - Decock, Julie

AU - Sermijn, Erica

AU - Bonduelle, Maryse

AU - Goelen, Guido

AU - Teugels, Erik

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Enhanced genomic instability has been recently reported in normal cells derived from BRCA1/2 mutation carriers when placed in vitro in non-physiological stress conditions. We present here original data which help to explain the observed genomic instability. Leucocytes from BRCA1/2 mutation carriers, sporadic breast cancer patients and controls were prepared for BRCA1 immunocytochemistry. We show that BRCA1 containing nuclear dot like structures are detectable in about 80% of the leucocytes from controls and sporadic breast cancer patients, but are absent in the majority of normal cells from BRCA1 as well as BRCA2 mutation carriers (also in their normal breast cells). Our results thus indicate that the genomic instability observed in normal cells from BRCA1 and BRCA2 mutation carriers is associated with a down-regulation of nuclear BRCA1 protein accumulation in the dot like structures. These results suggest in addition that immunocytochemical or alternative molecular screening strategies might help to identify women with a high risk for breast (ovarian) cancer even when the underlying genetic defect remains undetectable.

AB - Enhanced genomic instability has been recently reported in normal cells derived from BRCA1/2 mutation carriers when placed in vitro in non-physiological stress conditions. We present here original data which help to explain the observed genomic instability. Leucocytes from BRCA1/2 mutation carriers, sporadic breast cancer patients and controls were prepared for BRCA1 immunocytochemistry. We show that BRCA1 containing nuclear dot like structures are detectable in about 80% of the leucocytes from controls and sporadic breast cancer patients, but are absent in the majority of normal cells from BRCA1 as well as BRCA2 mutation carriers (also in their normal breast cells). Our results thus indicate that the genomic instability observed in normal cells from BRCA1 and BRCA2 mutation carriers is associated with a down-regulation of nuclear BRCA1 protein accumulation in the dot like structures. These results suggest in addition that immunocytochemical or alternative molecular screening strategies might help to identify women with a high risk for breast (ovarian) cancer even when the underlying genetic defect remains undetectable.

KW - BRCA1

KW - BRCA2

KW - Breast cancer

KW - Immunocytochemistry

UR - http://www.scopus.com/inward/record.url?scp=34247343751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247343751&partnerID=8YFLogxK

U2 - 10.1016/j.mrfmmm.2007.02.031

DO - 10.1016/j.mrfmmm.2007.02.031

M3 - Article

VL - 619

SP - 104

EP - 112

JO - Mutation Research

JF - Mutation Research

SN - 0027-5107

IS - 1-2

ER -